Första AP-fonden’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.2M | Sell |
52,000
-6,200
| -11% | -$2.76M | 0.15% | 125 |
|
|
2025
Q1 | $28.2M | Sell |
58,200
-500
| -0.9% | -$242K | 0.21% | 86 |
|
|
2024
Q4 | $23.6M | Sell |
58,700
-1,200
| -2% | -$483K | 0.17% | 99 |
|
|
2024
Q3 | $27.9M | Buy |
59,900
+6,000
| +11% | +$2.79M | 0.21% | 85 |
|
|
2024
Q2 | $25.3M | Sell |
53,900
-1,800
| -3% | -$844K | 0.22% | 83 |
|
|
2024
Q1 | $23.3M | Sell |
55,700
-18,000
| -24% | -$7.52M | 0.2% | 100 |
|
|
2023
Q4 | $30M | Buy |
73,700
+600
| +0.8% | +$244K | 0.3% | 62 |
|
|
2023
Q3 | $25.4M | Buy |
73,100
+1,000
| +1% | +$348K | 0.28% | 65 |
|
|
2023
Q2 | $25.4M | Buy |
72,100
+2,400
| +3% | +$845K | 0.27% | 69 |
|
|
2023
Q1 | $22M | Buy |
69,700
+8,300
| +14% | +$2.62M | 0.26% | 79 |
|
|
2022
Q4 | $17.7M | Buy |
61,400
+6,600
| +12% | +$1.91M | 0.2% | 108 |
|
|
2022
Q3 | $15.9M | Buy |
54,800
+900
| +2% | +$261K | 0.19% | 110 |
|
|
2022
Q2 | $15.2M | Sell |
53,900
-3,600
| -6% | -$1.01M | 0.2% | 111 |
|
|
2022
Q1 | $15M | Sell |
57,500
-19,800
| -26% | -$5.17M | 0.17% | 117 |
|
|
2021
Q4 | $17M | Buy |
77,300
+1,100
| +1% | +$242K | 0.17% | 120 |
|
|
2021
Q3 | $13.8M | Sell |
76,200
-2,100
| -3% | -$381K | 0.16% | 138 |
|
|
2021
Q2 | $15.8M | Buy |
78,300
+18,300
| +31% | +$3.69M | 0.19% | 113 |
|
|
2021
Q1 | $12.9M | Sell |
60,000
-11,300
| -16% | -$2.43M | 0.18% | 126 |
|
|
2020
Q4 | $16.9M | Buy |
71,300
+12,900
| +22% | +$3.05M | 0.25% | 73 |
|
|
2020
Q3 | $15.9M | Buy |
58,400
+23,100
| +65% | +$6.29M | 0.33% | 60 |
|
|
2020
Q2 | $10.2M | Buy |
35,300
+4,000
| +13% | +$1.16M | 0.27% | 84 |
|
|
2020
Q1 | $7.45M | Buy |
+31,300
| New | +$7.45M | 0.27% | 95 |
|